GENinCode plc (AIM: GENI) has conditionally raised £3.9m in gross proceeds through the issue of 388,145,000 new ordinary shares at 1p each, representing a 47.4pc discount to the closing middle
Six Biotechs to Watch in 2026: Breakthroughs, Setbacks, and Big Turning Points Ahead
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
Six Biotechs to Watch in 2026: Breakthroughs, Setbacks, and Big Turning Points Ahead
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
Share Talk Weekly Stock Market News Review, Sunday 21st December 2025
FTSE 100 ends session near all-time peak, closing up 59.65 points at 9,897, a gain of 0.6% that leaves the index edging closer to its record high of 9,930 set
GENinCode Plc (AIM: GENI) CARDIO inCode-Score® distribution with Sohin Genetics, Mexico
GENinCode Plc has entered into a commercial agreement with Sohin Genetics in Mexico to distribute its CARDIO inCode-Score® Polygenic Risk Score test, which is designed to help predict and prevent
RNS Hotlist with Zak Mir: AVCT, KOD, BZT, VLRM, ATC, GENI, ARV & N4P
The Times: The headline rate of inflation fell more than expected in November to a 10-month low – increasing expectations that the Bank of England will cut interest rates tomorrow. The
RNS Hotlist with Zak Mir: AAI, GENI, HAMA, DBOX, GNIP, NARF, ASAI, SWG, ECO, MPAL & UFO
Amazing AI plc (AQSE: AAI) AAI is a global fintech group with a Digital Asset Treasury Policy that provides online consumer loans and AI finance-related services. AAI announces that a circular
GENinCode Plc (AIM: GENI) up 33% on Thermo Fisher commercialisation deal
GENinCode Plc (AIM: GENI) shares climbed 33% after the company announced a major collaboration with Thermo Fisher Scientific to commercialise its CARDIO inCode-Score® Polygenic Risk Score test for predicting and
GENinCode up 32% on NY approval for genetic heart risk test
GENinCode PLC (AIM: GENI) jumped 32% to 2.84p in early trading after securing approval from the New York State Department of Health (NYSDOH) for its CARDIO inCode-Score test, which assesses
RNS Hotlist with Zak Mir: SVNS, ZEN, GLR, MFAI, ZIOC, UFO, NRGB, PLSR, ROCK, GENI, CASP, HAMA & G4M
Solvonis Therapeutics plc (SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, announced that its novel AI-discovered compound, SVN-015, targeting methamphetamine and cocaine use disorders,
RNS Hotlist with Zak Mir: BRES, RPI, TTA, SAAS, EGT, SOLG, ALTN, POLB, AREC, GENI & ZOO
The Telegraph: Co-op unveils £206m hit from cyber attack. IT shutdown led to data from retailers’ 6.5 million members being stolen
GENinCode PLC (AIM: GENI) Result of Retail Offer
GENinCode plc (AIM: GENI.L), a genetics company focused on the prevention of cardiovascular disease (“CVD”) and the early detection of ovarian cancer, announced on 14 February 2025 the launch of a fundraising comprising a